Psychosomatic disorders,characterized by significant contributions of psychosocial factors to the pathogenesis and progression of somatic organic diseases or functional impairments(e.g.,diabetes,essential hypertension...Psychosomatic disorders,characterized by significant contributions of psychosocial factors to the pathogenesis and progression of somatic organic diseases or functional impairments(e.g.,diabetes,essential hypertension,asthma,inflammatory bowel disease,and neurodermatitis),present unique diagnostic and therapeutic challenges[1].Traditional diagnostic frameworks,heavily reliant on clinicians’subjective judgment and limited by the qualitative nature of psychological assessments,often result in misdiagnosis or delayed detection.As a cornerstone of the Fourth Industrial Revolution,artificial intelligence(AI)has demonstrated transformative potential in medicine.In psychosomatic medicine,AI leverages advanced data analytics,machine learning,and natural language processing to decipher the intricate interplay between psychological and physiological mechanisms,offering novel tools for diagnosis,treatment,and prevention.However,its clinical integration raises critical ethical and operational concerns that warrant rigorous examination.展开更多
This review describes the conceptual and clinical relations between irritable bowel syndrome (IBS), other functional, somatoform, and mental disorders, and points to appropriate future conceptualizations. IBS is consi...This review describes the conceptual and clinical relations between irritable bowel syndrome (IBS), other functional, somatoform, and mental disorders, and points to appropriate future conceptualizations. IBS is considered to be a functional somatic syndrome (FSS) with a considerable symptom overlap with other FSSs like chronic fatigue syndrome or fibromyalgia syndrome. IBS patients show an increased prevalence of psychiatric symptoms and disorders, especially depression and anxiety. IBS is largely congruent with the concepts of somatoform and somatic symptom disorders. Roughly 50% of IBS patients complain of gastrointestinal symptoms only and have no psychiatric comorbidity. IBS concepts, treatment approaches, as well as health care structures should acknowledge its variability and multidimensionality by: (1) awareness of additional extraintestinal and psychobehavioral symptoms in patients with IBS; (2) general and collaborative care rather than specialist and separated care; and (3) implementation of “interface disorders” to abandon the dualistic classification of purely organic or purely mental disorders.展开更多
文摘Psychosomatic disorders,characterized by significant contributions of psychosocial factors to the pathogenesis and progression of somatic organic diseases or functional impairments(e.g.,diabetes,essential hypertension,asthma,inflammatory bowel disease,and neurodermatitis),present unique diagnostic and therapeutic challenges[1].Traditional diagnostic frameworks,heavily reliant on clinicians’subjective judgment and limited by the qualitative nature of psychological assessments,often result in misdiagnosis or delayed detection.As a cornerstone of the Fourth Industrial Revolution,artificial intelligence(AI)has demonstrated transformative potential in medicine.In psychosomatic medicine,AI leverages advanced data analytics,machine learning,and natural language processing to decipher the intricate interplay between psychological and physiological mechanisms,offering novel tools for diagnosis,treatment,and prevention.However,its clinical integration raises critical ethical and operational concerns that warrant rigorous examination.
文摘This review describes the conceptual and clinical relations between irritable bowel syndrome (IBS), other functional, somatoform, and mental disorders, and points to appropriate future conceptualizations. IBS is considered to be a functional somatic syndrome (FSS) with a considerable symptom overlap with other FSSs like chronic fatigue syndrome or fibromyalgia syndrome. IBS patients show an increased prevalence of psychiatric symptoms and disorders, especially depression and anxiety. IBS is largely congruent with the concepts of somatoform and somatic symptom disorders. Roughly 50% of IBS patients complain of gastrointestinal symptoms only and have no psychiatric comorbidity. IBS concepts, treatment approaches, as well as health care structures should acknowledge its variability and multidimensionality by: (1) awareness of additional extraintestinal and psychobehavioral symptoms in patients with IBS; (2) general and collaborative care rather than specialist and separated care; and (3) implementation of “interface disorders” to abandon the dualistic classification of purely organic or purely mental disorders.
